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Purpose: Moxibustion therapy is a commonly used treatment in Oriental medicine. Here, we
provide evidence for the safety of long-term moxibustion therapy.
Subjects: and design: Forty-five subjects (10 men and 35 women) who complained of chronic
fatigue were divided into control (5 men and 15 women) and experimental groups (5 men
and 20 women) in a randomized double-blind setting. The experimental group was treated
with moxibustion to CV4 and CV8 for 4 weeks (administered three times per week); the control
group was exposed to simulated burning of moxibustion. Complete blood counts, blood chem-
istry, and urinalysis results were analyzed before and after each trial.
Results: The absolute and relative number of peripheral blood cells did not differ between the
pre- and posttreatment measurements of either group. No significant changes in blood chem-
istry or urinalysis data were observed in either group.
Conclusions: These results suggest that indirect moxibustion has no effect on blood chemistry
or urine and is safe for clinical use. These data could be used as reference data for further
moxibustion studies.1. Introduction
Moxibustion treatment plays an important therapeutic role
in traditional Oriental medicine and has been attracting
a great deal of attention worldwide [1]. The Korean Health
Industry Development Institute reported that moxibustion
is the third most popular Oriental therapy. In Korea, 67% of
Oriental doctors use moxibustion in their medical practices,
and Oriental doctors have stated that the therapeutic
efficacy and positive responses from patients are the
biggest advantages of moxibustion therapy [2,3]. The
Korean national health insurance paid over 37 billion won
for moxibustion treatments in 2009 [4].mune Research Center, Daejeon O
a.
uncture InstituteA number of studies on the effects of moxibustion
treatment have been conducted, including studies on its
ability to control joint pain or correct breech birth [5e7]. In
particular, moxibustion therapy is regarded as a prospec-
tive treatment for chronic disorders and cold symptoms
[8,9]. However, only a limited number of studies have
investigated moxibustion [10]. Few data exist on the bio-
logical mechanisms of moxibustion treatment or the safety
of moxibustion therapy [11,12].
Evidence-based complementary medicine strongly
demands scientific data that are derived from clinical
research [13,14]. The present study provides clinical data
regarding the safety of indirect moxibustion exposure via
a randomized clinical trial.riental Hospital of Daejeon University, 22-5 Daehung-dong, Jung-gu,
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2.1. Subjects and randomization
Adults complaining of fatigue who did not work nights,
drink alcohol, smoke, use medications, and who were not
overweight were recruited for participation in this study.
Subjects with abnormalities on hematological or radiolog-
ical tests were excluded. Of those recruited, 45 subjects
(10 men and 35 women) were included in this study (median
age: 44 years; range: 3263 years). Subjects were divided
into either the moxibustion group (5 men and 20 women) or
the control group (5 men and 15 women) by block
randomization. Informed consent was obtained from each
subject, and the ethics committee of Daejeon University
Hospital approved the study protocol (#DJOMC-36).
2.2. Study design and moxibustion treatment
A licensed doctor administered moxibustion to two acu-
points on the conception vessel meridian, CV4, and CV8,
three times per week for 4 weeks. One moxa corn (3.5 g of
wormwood fiber on top of salt-basement inside a bamboo
container; 30 mm in diameter; 40 mm in length; KyeGoo
Inc., Incheon, Korea) was burned in each 30-minute session.
A thermal insulator-inserted moxa was used for the control
group. An infrared lamp was used in both groups to main-
tain a high temperature over the abdominal area. The peak
temperature of the skin during moxibustion therapy was
75C, while the peak temperate recorded for the control
group was 37C.
2.3. Complete blood count, biochemical
parameters, and urinalysis
Blood and urine samples were obtained from each subject
1 hour prior to the first moxibustion session and 1 hour afterTable 1 Changes in complete cell counts following moxibustion
Hematological parameter Control (nZ 20)
Before A
White blood cell (102/mL) 55.3 106 54
Differential counts (%)
Neutrophils 55.2 7.8 55
Lymphocytes 40.2 7.7 41
Monocytes 4.6 1.4 3.
Red blood cell (104/mL) 448.6 25.7 43
Hemoglobin (g/dL) 13.6 1.5 13
Hematocrit (%) 40.1 3.9 39
MCV (fL) 84.1 20.9 88
MCH (pg) 29.4 4.0 30
MCHC (g/dL) 37.3 14.5 34
ESR (mm/hr) 11.1 6.1 15
Platelet (104/mL) 24.3 7.5 21
MCV, mean cell volume; MCH, mean cell hemoglobin; HCHC, mean co
tation rate.the final moxibustion session. The complete blood count
included a red blood cell count, white blood cell count and
differential, and platelet count. Hemoglobin and hematocrit
levels were determined using an auto-hematoanalyzer
(Celltack-a; Nihon, Japan). The erythrocyte sedimentation
rate was also measured. Blood biochemical parameters,
including total protein, albumin, aspartate amino-
tranferase, alanine aminotransferase, alkaline phosphatase,
gamma-glutamyl transpeptidase, lactate dehydrogenase,
creatinine, blood urea nitrogen, total cholesterol, triglyc-
eride, and glucose were determined using a chemical
analyzer (AU 400; Olympus, Tokyo, Japan). Urinalysis was
performed using an auto-urine analyzer (Urisys 1800 system;
Roche, Indianapolis, IN, USA).
2.4. Statistical analysis
Changes in the complete blood counts, biochemical
parameters, and urinalysis data between the two groups,
both pre- and postmoxibustion, were analyzed using inde-
pendent two-sample t-tests. Statistical significance was
defined as p< 0.05.
3. Results
3.1. Changes in complete cell counts
All of the complete cell count parameters measured in both
groups were within normal ranges. After 4 weeks of mox-
ibustion therapy, no parameters had significantly changed
from the pretreatment values in either group (Table 1).
3.2. Change in biochemical parameters
All of the biochemical parameters measured in both groups
were within normal ranges, and no parameters were
significantly different compared with the pretreatmenttreatment.
Moxibustion (nZ 25)
fter Before After
.7 15.7 56.4 13.2 55.1 11.6
.0 8.1 59.4 7.0 58.8 7.6
.4 8.0 36.9 6.9 37.9 7.7
6 1.0 3.7 1.0 3.2 1.1
8.8 22.5 446.4 46.6 445.3 47.3
.3 1.4 13.7 1.7 13.4 1.7
.0 3.5 39.6 4.5 39.33 4.4
.9 5.4 88.7 4.1 88.4 4.2
.3 2.4 30.6 1.7 30.1 1.8
.1 0.8 34.5 0.7 34.0 0.8
.1 8.7 12.5 10.3 13.9 10.6
.2 3.9 24.1 5.8 22.6 4.4
rpuscular hemoglobin concentration; ESR, erythrocyte sedimen-
Table 2 Changes in biochemical parameters following moxibustion treatment.
Biochemical values Control (nZ 20) Moxibustion (nZ 25)
Before After Before After
Total protein (g/dL) 7.7 0.4 7.5 0.5 7.6 0.3 7.5 0.4
Albumin (g/dL) 4.6 0.2 4.5 0.2 4.6 0.2 4.5 0.2
Alkaline phosphatase (U/L) 68.3 16.6 67.6 18.6 67.5 19.4 65.7 17.4
AST (U/L) 24.4 5.7 24.4 5.7 22.2 5.9 22.2 5.9
ALT (U/L) 22.6 7.6 22.0 9.7 19.6 8.1 18.4 7.2
GGT (U/L) 22.6 11.7 24.8 14.8 18.9 8.4 18.8 8.4
Lactate dehydrogenase (U/L) 171.2 30.8 151.3 20.3 172.1 33.6 143.2 25.1
Creatinine (mg/dL) 0.9 0.1 0.9 0.1 0.9 0.2 0.8 0.2
Blood urea nitrogen (mg/dL) 12.6 4.5 13.6 4.1 13.5 3.0 12.9 3.1
Total cholesterol (mg/dL) 195 38.4 189 47.9 199.4 46.7 203.6 40.4
Triglycerides (mg/dL) 130.8 70.0 113.3 58.5 149.6 101.5 122.3 65.4
Glucose (mg/dL) 93.0 11.9 89.5 14.2 97.1 15.0 93.6 12.2
AST, aspartate aminotranferase; ALT, alanine aminotransferase; GGT, gamma-glutamyl transpeptidase.
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(Table 2).
3.3. Changes in urinalysis data
Prior to moxibustion treatment, 10 and 9 subjects in the
control and moxibustion groups, respectively, showed
abnormal urinalysis results. After 4 weeks of moxibustion,
an additional subject in each group showed leukocytes in
the urine. However, no significant differences between the
groups were observed between pre- and postmoxibustion
treatment values (Table 3).4. Discussion
Acupuncture and moxibustion therapy are the main treat-
ments used in traditional Oriental medicine. Moxibustion
treatment provides warm energy, expels cold-damp stag-
nation, and enhances immunity, whereas acupuncture
circulates qi and energy through the meridians [15]. Thus,
moxibustion has been applied to patients with chronicTable 3 Changes in urinalysis data following moxibustion
treatment.
Urinalysis (No. of
abnormal
patients, %)
Control (nZ 20) Moxibustion
(nZ 25)
Before After Before After
Albumin 0 (0%) 0 (0%) 4 (16%) 2 (8%)
Leukocytes 1 (5%) 2 (10%) 8 (32%) 7 (28%)
Nitrite 0 (0%) 1 (5%) 0 (0%) 0 (0%)
Glucose 1 (5%) 0 (0%) 0 (0%) 0 (0%)
Urobilinogen 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Ketones 0 (0%) 0 (0%) 3 (12%) 2 (8%)
Bilirubin 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Blood 10 (50%) 6 (30%) 9 (36%) 7 (28%)
Data are expressed as the number patients with abnormalities
and percentages of each respective group.pathological conditions and has shown positive clinical
effects on diverse cold-associated symptoms [16,17].
Approximately 60 clinical trials have been conducted to
study the effects of moxibustion on various pathological
conditions. However, no clinical study has primarily focused
on the safety of moxibustion treatment. This is the first
report to include blood cell counts, biochemical parame-
ters, and urinalysis results after indirect moxibustion
treatment to CV4 and CV8 in normal subjects. All blood and
chemical values of the subjects were within normal physi-
ological ranges before initiating treatment.
Indirect moxibustion is generally believed to be very
safe, and our results show that blood cell counts and
biochemical parameters are not affected by indirect mox-
ibustion. The initial urinalysis data showed leukocyte
abnormalities in 10 and 9 subjects in the control and
moxibustion groups, respectively. These subjects were all
women, and no subject had abnormalities related to blood
urea nitrogen or creatinine. One woman in the moxibustion
group complained of a slight itching sensation around CV8,
but she was able to finish the moxibustion treatment.
The effects of moxibustion differ depending on the
method, location, quantity, duration, and, sometimes, the
practitioner of the treatment. CV4 and CV8 are acupoints
that Oriental doctors frequently choose for moxibustion
[2]. Indirect moxibustion at CV8 and CV4 has shown a clin-
ically therapeutic effect for primary dysmenorrhea [18,19].
Several animal-based studies have shown an increase in B-
lymphocytes and the activation of natural killer cells and
macrophages following moxibustion treatment [20e22].
Another clinical study revealed the immunomodulating
effects of moxibustion, such as the prevention of a noso-
comial infection [23]. However, in this study, indirect
moxibustion at CV4 and CV8 did not affect the cellular
distribution of lymphocytes (CD4 and CD8 T-cells, B-cells,
or natural killer cells) in the peripheral blood, as shown by
fluorescence-activated cell-sorting analysis (data not
shown).
The results of this study are limited to interpreting the
general safety of moxibustion treatment, however, because
this study was performed using indirect moxibustion at only
two acupoints. However, this study provides the first
Safety of moxibustion 265objective blood parameter data that were measured both
before and after moxibustion treatment, which could be
used as a clinical reference.
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